Efficacy and Safety of Probiotic Treatment as a Supportive Therapy in Eradication of H. Pylori

The aim of the study is to establish efficacy and safety of Normia® probiotic, used as an add-on therapy in treatment of H. Pylori infection with the standard triple therapy approach. The primary objective in the study is determination of efficacy of Normia® probiotic as a supportive therapy in achieving a higher percentage of eradication of H. Pylori. The secondary objectives are to assess: * Safety profile of Normia® probiotic in everyday use, e.g. reduction in number of side-effects and better compliance to the eradication therapy * Safety and efficacy of Normia® probiotic in different demographic subgroups